chrX-154564361-G-GC

Variant names:

• chrX-154564361-G-GC
• rs782178147
• NM_001099857.5:c.1167dupC

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_Strong PP5_Very_Strong

The NM_001099857.5(IKBKG):​c.1167dupC​(p.Glu390ArgfsTer5) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (★★).

• Frequency: Genomes: not found (cov: 0)
• Consequence: IKBKG NM_001099857.5 frameshift
• Clinical Significance: Pathogenic criteria provided, multiple submitters, no conflicts P:7 O:1
• Conservation: PhyloP100: -0.0810
• Publications: 3 publications found

Genes affected

IKBKG (HGNC:5961): (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma) This gene encodes the regulatory subunit of the inhibitor of kappaB kinase (IKK) complex, which activates NF-kappaB resulting in activation of genes involved in inflammation, immunity, cell survival, and other pathways. Mutations in this gene result in incontinentia pigmenti, hypohidrotic ectodermal dysplasia, and several other types of immunodeficiencies. A pseudogene highly similar to this locus is located in an adjacent region of the X chromosome. [provided by RefSeq, Mar 2016]

IKBKG Gene-Disease associations (from GenCC):

• ectodermal dysplasia and immunodeficiency 1

  Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
• IKBKG-related immunodeficiency with or without ectodermal dysplasia

  Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
• incontinentia pigmenti

  Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, G2P, Orphanet
• ectodermal dysplasia and immune deficiency

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome

  Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
• immunodeficiency 33

  Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

ACMG classification

Our verdict: Pathogenic. The variant received 12 ACMG points.

• PVS1: Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 13 pathogenic variants in the truncated region.
• PP5: Variant X-154564361-G-GC is Pathogenic according to our data. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-154564361-G-GC is described in CliVar as Pathogenic. Clinvar id is 372387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
IKBKG	NM_001099857.5	c.1167dupC	p.Glu390ArgfsTer5	frameshift_variant	Exon 10 of 10	ENST00000594239.6	NP_001093327.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
IKBKG	ENST00000594239.6	c.1167dupC	p.Glu390ArgfsTer5	frameshift_variant	Exon 10 of 10	1	NM_001099857.5	ENSP00000471166.1

Frequencies

GnomAD3 genomes Cov.: 0

GnomAD2 exomes AF: 0.000107 AC: 7 AN: 65174 AF XY: 0.00

Gnomad AFR exome AF: 0.000417

Gnomad AMR exome AF: 0.00

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.000445

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000855

Gnomad OTH exome AF: 0.00

GnomAD4 exome Cov.: 0

GnomAD4 genome Cov.: 0

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:7 Other:1

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Incontinentia pigmenti syndrome Pathogenic:3 Other:1

-

Juno Genomics, Hangzhou Juno Genomics, Inc

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

PVS1_Moderate+PS4+PP1_Strong+PS3+PM2_Supporting -

Sep 01, 2001

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

-

Department of Medical Genetics, College of Basic Medicine, Army Medical University

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: research

- -

-

GeneReviews

Significance: not provided

Review Status: no classification provided

Collection Method: literature only

- -

Immunodeficiency 33 Pathogenic:1

May 10, 2023

Undiagnosed Diseases Network, NIH

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

not provided Pathogenic:1

Dec 14, 2022

GeneDx

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

Published functional studies demonstrate a damaging effect on protein function (Ohnishi et al., 2017; Kawai et al., 2012); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 30 amino acids are lost and replaced with 4 incorrect amino acids; truncated region removes a portion of the zinc finger domain (HGMD); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22517901, 18350553, 11484156, 18347290, 30982207, 31713830, 32035679, 34061330, 11047757, 27577878, 18222329, 11179023, 28702714) -

Ectodermal dysplasia and immunodeficiency 1 Pathogenic:1

Sep 01, 2001

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

Incontinentia pigmenti syndrome;C1846008:Ectodermal dysplasia and immunodeficiency 1;C1970879:Immunodeficiency 33 Pathogenic:1

Oct 27, 2021

Fulgent Genetics, Fulgent Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
PhyloP100		-0.081

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.010		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs782178147; hg19: chrX-153792576;